You can buy or sell CBPO and other stocks, options, ETFs, and crypto commission-free!
China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. Read More The company was founded in 2002 and is headquartered in Beijing, China.
52 Week High
52 Week Low
Yahoo FinanceMar 20
New Strong Sell Stocks for March 20th
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today: Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: China Biologic Products Holdings, Inc. CBPO is a manufacturer of human plasma-based biopharmaceutical products. The Zacks Consensus Estimate for its current year earnings has been revised 6% downward over the last 30 days. Donegal Group Inc. DGICA is an insurance holding company. The Zacks Consensus Estimate for its current year earnings has been revised 31.3% downw...
Yahoo FinanceMar 19
See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.
China Biologic Products Holdings Inc NASDAQ/NGS:CBPO View full report here! Summary Bearish sentiment is low Bearish sentiment Short interest | Positive Short interest is low for CBPO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows o...
Stock Price, News, & Analysis for China Biologic Products
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-den...
Expected May 3, After Hours